No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
CSPCY CSPC PHARMACEUTICAL GROUP LIMITED UNSPON ADS EACH REP 4 ORD SHS
- 2.232
- -0.048-2.11%
15min DelayTrading Jan 28 12:06 ET
6.39BMarket Cap9.26P/E (TTM)
2.240High2.230Low2.76KVolume2.240Open2.280Pre Close6.17KTurnover0.00%Turnover Ratio8.18P/E (Static)2.86BShares3.70952wk High1.33P/B6.39BFloat Cap2.15052wk Low0.07Dividend TTM2.86BShs Float5.800Historical High3.27%Div YieldTTM0.44%Amplitude2.150Historical Low2.231Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
CSPC PHARMACEUTICAL GROUP LIMITED UNSPON ADS EACH REP 4 ORD SHS(CSPCY.US) will release its financial report after market close on November 14th.
$CSPC PHARMACEUTICAL GROUP LIMITED UNSPON ADS EACH REP 4 ORD SHS (CSPCY.US)$ will release its financial report after the market closes on November 14th. How was the previous performance? $CSPC PHARMACEUTICAL GROUP LIMITED UNSPON ADS EACH REP 4 ORD SHS (CSPCY.US)$ Revenue in Q1 2024 was 89.82734.
CSPC Pharmaceutical Group Limited Goes Ex Dividend Tomorrow
CSPC PHARMACEUTICAL GROUP LIMITED UNSPON ADS EACH REP 4 ORD SHS To Go Ex-Dividend On November 1st, 2024 With 0.08212 USD Dividend Per Share
August 26th (Eastern Time) - $CSPC PHARMACEUTICAL GROUP LIMITED UNSPON ADS EACH REP 4 ORD SHS(CSPCY.US)$ is trading ex-dividend on November 1st, 2024.Shareholders of record on November 1st, 2024
CSPC PHARMACEUTICAL GROUP LIMITED UNSPON ADS EACH REP 4 ORD SHS To Go Ex-Dividend On June 3rd, 2024 With 0.07158 USD Dividend Per Share
March 22nd - $CSPC PHARMACEUTICAL GROUP LIMITED UNSPON ADS EACH REP 4 ORD SHS(CSPCY.US)$ is trading ex-dividend on June 3rd, 2024. Shareholders of record on June 3rd, 2024 will receive 0.07158 USD
Corbus Pharma Reverses Gains on Common Stock Offering
Corbus Pharma Surges After Early Phase 1 Data for Tumor Candidate
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock the Full List